Comprehensive Evaluation of the Effects of Enalapril on Matrix Metalloproteinases Levels in Hypertension

Circulating matrix metalloproteinases and their inhibitors in hypertension

(2012) Vanessa Fontana et al.   CLINICA CHIMICA ACTA

Fluorescence Detection of MMP-9. I. MMP-9 Selectively Cleaves Lys-Gly-Pro-Arg-Ser-Leu-Ser-Gly-Lys Peptide

(2012) Rafal Fudala et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Consistent Alterations of Circulating Matrix Metalloproteinases Levels in Untreated Hypertensives and in Spontaneously Hypertensive Rats: A Relevant Pharmacological Target

(2011) Vanessa Fontana et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Ramiprilate Inhibits Functional Matrix Metalloproteinase Activity in Crohn’s Disease Fistulas

(2011) Eva Efsen et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

MMP-9 Inhibition by ACE Inhibitor Reduces Oxidized LDL-Mediated Foam-Cell Formation

(2011) Chiari Kojima et al.   Journal of Atherosclerosis and Thrombosis

Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients

(2011) Kim-Thanh Ong et al.   JOURNAL OF HYPERTENSION

Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells

(2011) Tatiane C. Izidoro-Toledo et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Losartan exerts no protective effects against acute pulmonary embolism-induced hemodynamic changes

(2011) Carlos A. Dias-Junior et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Matrix metalloproteinases: Targets for doxycycline to prevent the vascular alterations of hypertension

(2011) Michele M. Castro et al.   PHARMACOLOGICAL RESEARCH

Doxycycline Dose-dependently Inhibits MMP-2-Mediated Vascular Changes in 2K1C Hypertension

(2010) Danielle A. Guimaraes et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension

(2010) CS Ceron et al.   BRITISH JOURNAL OF PHARMACOLOGY

Captopril directly inhibits matrix metalloproteinase-2 activity in continuous ambulatory peritoneal dialysis therapy

(2010) Daisuke Yamamoto et al.   CLINICA CHIMICA ACTA

Different actions of losartan and ramipril on adipose tissue activity and vascular remodeling biomarkers in hypertensive patients

(2010) Giuseppe Derosa et al.   HYPERTENSION RESEARCH

Matrix Metalloproteinase Inhibition Improves Cardiac Dysfunction and Remodeling in 2-Kidney, 1-Clip Hypertension

(2010) Élen Rizzi et al.   JOURNAL OF CARDIAC FAILURE

Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension

(2010) Diogo M. O. Marçal et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Positive correlations between serum and plasma matrix metalloproteinase (MMP)-2 or MMP-9 levels in disease conditions

(2009) Raquel F. Gerlach et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Pharmacological Implications of MMP-9 Inhibition by ACE Inhibitors

(2009) Daisuke Yamamoto et al.   CURRENT MEDICINAL CHEMISTRY

Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin

(2009) Marcelo F. Montenegro et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Reinventing the ACE inhibitors: some old and new implications of ACE inhibition

(2009) Kashif Hanif et al.   HYPERTENSION RESEARCH

Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling

(2009) Michele M. Castro et al.   MATRIX BIOLOGY

Serum levels of MMP-9 and TIMP-1 in primary hypertension and effect of antihypertensive treatment

(2008) Ibrahim Koral Onal et al.   European Journal of Internal Medicine

Inhibitory profiles of captopril on matrix metalloproteinase-9 activity

(2008) Daisuke Yamamoto et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats

(2008) Marcio L.L. Martinez et al.   EUROPEAN JOURNAL OF PHARMACOLOGY